Astrocytoma, IDH-Mutant, Grade 4 — Trials

Astrocytoma, IDH-Mutant, Grade 4 — Trials · CancerIndex

Clinical trials

Registered studies

16 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 12
Recruiting: 9
Ph III recruiting: 1
Growth YoY: —
Industry share: 8%
Top sponsor: Mayo Clinic
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (0)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07831369	VISTA: Valproic Acid, Irinotecan, and Simvastatin for Recurrent Glioma	recruiting	Phase 2	52	Inova Health Care ServicesOTHER	1	Sep 21, 2026	clinicaltrials
NCT07468136	Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas	recruiting	Phase 1 / Phase 2	33	Mayo ClinicOTHER	1	Jun 24, 2026	clinicaltrials